Tag results:

influenza

Mechanical Control of Innate Immune Responses against Viral Infection Revealed in a Human Lung Alveolus Chip

[Nature Communications] Researchers used a human lung alveolus chip that experienced cyclic breathing-like deformations to investigate whether physical forces influenced innate immune responses to viral infection.

Next-Generation T Cell-Activating Vaccination Increases Influenza Virus Mutation Prevalence

[Science Advances] To determine the potential for viral adaptation to T cell responses, scientists probed the full influenza virus genome by next-generation sequencing directly ex vivo from infected mice, in the context of an experimental T cell-based vaccine, an H5N1-based viral vectored vaccinia vaccine Wyeth/IL-15/5Flu, versus the current standard-of-care.

Role of Hormones in the Pregnancy and Sex-Specific Outcomes to Infections with Respiratory Viruses

[Immunological Reviews] The authors address the unique role of adaptive and innate immune cells in the control of pathogenic respiratory viruses and how pregnancy and specific hormones can impact their effector actions.

Reduced Protection of RIPK3-Deficient Mice against Influenza by Matrix Protein 2 Ectodomain Targeted Active and Passive Vaccination Strategies

[Cell Death & Disease] The authors observed that the protection against IAV after active vaccination with matrix protein 2 ectodomain viral antigen was lost was Ripk3−/− mice.

Pandemic Influenza a (H1N1) Virus Causes Abortive Infection of Primary Human T Cells

[Emerging Microbes & Infections] Different T cell subpopulations have distinct characterizations and functions, and scientists revealed the high heterogeneity of susceptibility to viral infection and biological responses such as apoptosis in various CD4+ T and CD8+ T cell subsets through single-cell transcriptome analyses.

Antibody Decay, T Cell Immunity and Breakthrough Infections Following Two SARS-CoV-2 Vaccine Doses in Inflammatory Bowel Disease Patients Treated with Infliximab and Vedolizumab

[Nature Communications] The authors reported SARS-CoV-2 vaccine-induced immune responses and breakthrough infections in patients with inflammatory bowel disease, who were treated either with an anti-tumor necrosis factor antibody, infliximab, or with vedolizumab targeting a gut-specific anti-integrin that did not impair systemic immunity.

Popular